Cytosorbents CorporationCTSONASDAQ
Loading
Stockholders Equity Over TimeContracting
Percentile Rank64
3Y CAGR-43.8%
5Y CAGR+26.6%
Studio
Year-over-Year Change

Net worth of the company (assets minus liabilities)

3Y CAGR
-43.8%/yr
vs +57.1%/yr prior
5Y CAGR
+26.6%/yr
Recent deceleration
Acceleration
-100.9pp
Decelerating
Percentile
P64
Within normal range
vs 5Y Ago
3.2x
Strong expansion
Streak
4 yr
Consecutive declineContracting
PeriodValueYoY Change
2024$11.11M-52.3%
2023$23.28M-34.2%
2022$35.37M-43.5%
2021$62.58M-21.0%
2020$79.22M+2217.6%
2019$3.42M-79.8%
2018$16.93M+65.0%
2017$10.26M+2264.8%
2016$-474088.00-105.8%
2015$8.21M-